ADCT · ADC Therapeutics SA · Investor Relations
$1.25
-0.05 (-3.78%)
At close · Nov 20
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$165.97M
Shares
127.67M
Volume · Nov 19
752.42K
Avg daily vol (3M)
1.57M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-19 | Jefferies Global Healthcare Conference | Conference |
| 2026-11-10 | Guggenheim Third Annual Healthcare Innovation Conference | Conference |
| 2026-08-13 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-03 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-04 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-10 | Earnings conference call (announced in 8-K) | Earnings call |
| 2025-11-19 | Jefferies Global Healthcare Conference | Conference |
| 2025-11-11 | Guggenheim Second Annual Healthcare Innovation Conference | Conference |
| 2025-11-03 | Stephens Biotechnology Virtual Fireside Chats 2025 | Event |
Key facts
CIK
1771910
CUSIP
H0036K147
13F (30d)
116 filings
102 filers
Visit website
Investor relations